Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 2
2006 3
2007 2
2008 2
2009 5
2011 4
2012 1
2013 5
2014 13
2015 7
2016 8
2017 7
2018 8
2019 6
2020 10
2021 10
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Results by year
Filters applied: . Clear all
Page 1
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.
Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, Szer J, Wagner EM, Zuckerman T, Mahuzier B, Xu J, Wilke C, Gandhi KK, Socié G; REACH2 Trial Group. Zeiser R, et al. N Engl J Med. 2020 May 7;382(19):1800-1810. doi: 10.1056/NEJMoa1917635. Epub 2020 Apr 22. N Engl J Med. 2020. PMID: 32320566 Clinical Trial.
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.
Aguilar-Guisado M, Espigado I, Martín-Peña A, Gudiol C, Royo-Cebrecos C, Falantes J, Vázquez-López L, Montero MI, Rosso-Fernández C, de la Luz Martino M, Parody R, González-Campos J, Garzón-López S, Calderón-Cabrera C, Barba P, Rodríguez N, Rovira M, Montero-Mateos E, Carratalá J, Pérez-Simón JA, Cisneros JM. Aguilar-Guisado M, et al. Among authors: perez simon ja. Lancet Haematol. 2017 Dec;4(12):e573-e583. doi: 10.1016/S2352-3026(17)30211-9. Epub 2017 Nov 15. Lancet Haematol. 2017. PMID: 29153975 Clinical Trial.
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.
Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F; REACH3 Investigators. Zeiser R, et al. N Engl J Med. 2021 Jul 15;385(3):228-238. doi: 10.1056/NEJMoa2033122. N Engl J Med. 2021. PMID: 34260836 Clinical Trial.
T-cells immune response controls the high incidence of adenovirus infection in adult allogenic hematopoietic transplantation recipients.
Sánchez-Céspedes J, Marrugal-Lorenzo JA, Martín-Gandul C, Rodríguez-Torres N, Montero-Mateos E, Serna-Gallego A, Escamilla-Gómez V, Merino L, Espigado I, Pachón J, Pérez-Simón JA, Aguilar-Guisado M. Sánchez-Céspedes J, et al. Among authors: perez simon ja. Haematologica. 2021 Jan 1;106(1):275-278. doi: 10.3324/haematol.2019.240101. Haematologica. 2021. PMID: 31974194 Free PMC article. No abstract available.
HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT.
Rodriguez-Barbosa JI, Schneider P, Weigert A, Lee KM, Kim TJ, Perez-Simon JA, Del Rio ML. Rodriguez-Barbosa JI, et al. Among authors: perez simon ja. Cell Mol Immunol. 2019 Jul;16(7):679-682. doi: 10.1038/s41423-019-0241-1. Epub 2019 Jun 3. Cell Mol Immunol. 2019. PMID: 31160757 Free PMC article. No abstract available.
The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejection.
Del Rio ML, Nguyen TH, Tesson L, Heslan JM, Gutierrez-Adan A, Fernandez-Gonzalez R, Gutierrez-Arroyo J, Buhler L, Pérez-Simón JA, Anegon I, Rodriguez-Barbosa JI. Del Rio ML, et al. Among authors: perez simon ja. Transl Res. 2022 Jan;239:103-123. doi: 10.1016/j.trsl.2021.08.006. Epub 2021 Aug 27. Transl Res. 2022. PMID: 34461306 Free article.
Severe hemophagocytosis syndrome: macrophage cannibalism.
Ruiz Mercado M, Calderón-Cabrera C, Morales Camacho R, Borrero Martín JJ, Domínguez Muñoz Mde L, Bernal Ruiz R, Pérez-Simón JA. Ruiz Mercado M, et al. Among authors: perez simon ja. Eur J Haematol. 2014 Nov;93(5):453-4. doi: 10.1111/ejh.12297. Epub 2014 Mar 19. Eur J Haematol. 2014. PMID: 24612295 No abstract available.
80 results